Masimo (MASI) Share-based Compensation (2009 - 2026)
Masimo (MASI) recorded quarterly Share-based Compensation of $8.9 million in Q2 2026, little changed quarter-over-quarter from $8.9 million in Q1 2026, and down 2.2% on a YoY basis from $9.1 million in Q2 2025.
Masimo (MASI) Share-based Compensation (2009 - 2026) Analysis & Trends
Masimo's Share-based Compensation history runs 18 years deep, the most recent figure standing at $8.9 million for Q2 2026.
- In Q2 2026, Share-based Compensation fell 2.2% year-over-year to $8.9 million; the TTM figure through Apr 2026 stood at $35.6 million (down 2.47% YoY), while the FY2026 annual figure was $35.8 million, down 0.83% from the prior year.
- Share-based Compensation was $8.9 million for Q2 2026 at Masimo, roughly flat from $8.9 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $17.3 million in Q3 2022 to a low of -$8.6 million in Q3 2023.
- Historically, Share-based Compensation has averaged $7.9 million across 5 years, with a median of $8.8 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation plunged 149.71% in 2023, then jumped 545.45% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $6.0 million in 2022, then soared by 41.67% to $8.5 million in 2023, then gained by 24.71% to $10.6 million in 2024, then declined by 12.26% to $9.3 million in 2025, then dropped by 4.3% to $8.9 million in 2026.
- The last three Share-based Compensation figures came in at $8.9 million (Q2 2026), $8.9 million (Q1 2026), and $9.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 45.40 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 35.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 43.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 8.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 8.90 Mn |
| Apr 4, 2026 | 8.90 Mn |
| Jan 3, 2026 | 8.90 Mn |
| Jan 3, 2026 | 8.90 Mn |
| Sep 27, 2025 | 9.30 Mn |
| Sep 27, 2025 | 9.30 Mn |
| Jun 28, 2025 | 8.50 Mn |
| Jun 28, 2025 | 8.50 Mn |
| Mar 29, 2025 | 9.10 Mn |
| Mar 29, 2025 | 9.10 Mn |
| Dec 28, 2024 | 10.60 Mn |
| Dec 28, 2024 | 10.60 Mn |
| Sep 28, 2024 | 4.90 Mn |
| Sep 28, 2024 | 4.90 Mn |
| Jun 29, 2024 | 11.90 Mn |
| Jun 29, 2024 | 11.90 Mn |
| Mar 30, 2024 | 8.70 Mn |
| Mar 30, 2024 | 8.70 Mn |
| Dec 30, 2023 | 8.50 Mn |
| Dec 30, 2023 | 8.50 Mn |